These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35599038)

  • 1. Preventing erosion of oral polio vaccine acceptance: A role for vaccinator visits and social norms.
    SteelFisher GK; Caporello H; McIntosh R; Muhammad Safdar R; Desomer L; Chimenya D; Abdelwahab J; Ratna J; Rutter P; O'Reilly D; Gilani BI; Williams MR; Ben-Porath EN; Blendon RJ
    Vaccine; 2022 Jun; 40(27):3752-3760. PubMed ID: 35599038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Threats to polio eradication in high-conflict areas in Pakistan and Nigeria: a polling study of caregivers of children younger than 5 years.
    SteelFisher GK; Blendon RJ; Guirguis S; Brulé A; Lasala-Blanco N; Coleman M; Petit V; Ahmed M; Mataruse N; Corkum M; Nisar M; Ben-Porath EN; Gigli S; Sahm C
    Lancet Infect Dis; 2015 Oct; 15(10):1183-1192. PubMed ID: 26179316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Threats to oral polio vaccine acceptance in Somalia: Polling in an outbreak.
    SteelFisher GK; Blendon RJ; Haydarov R; Lodge W; Caporello H; Guirguis S; Anand S; Birungi J; Williams MR; Ben-Porath EN; O'Reilly D; Sahm C
    Vaccine; 2018 Jul; 36(31):4716-4724. PubMed ID: 29958738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding threats to polio vaccine commitment among caregivers in high-priority areas of Afghanistan: a polling study.
    SteelFisher GK; Blendon RJ; Guirguis S; Lodge W; Caporello H; Petit V; Coleman M; Williams MR; Parwiz SM; Corkum M; Gardner S; Ben-Porath EN
    Lancet Infect Dis; 2017 Nov; 17(11):1172-1179. PubMed ID: 28818541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strengthening polio vaccine demand in Ghana: Understanding the factors influencing uptake of the vaccine and the effectiveness of different message frames.
    Lohiniva AL; Nurzhynska A; Mueed A; Ali A; Ahmed K; Ayiku P; Amo-Adjei J; Kawakatsu Y; Shetye M; Greiner K; McIntosh R
    PLoS One; 2023; 18(2):e0279809. PubMed ID: 36763581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of COVID-19 on polio vaccination in Pakistan: a concise overview.
    Din M; Ali H; Khan M; Waris A; Ullah S; Kashif M; Rahman S; Ali M
    Rev Med Virol; 2021 Jul; 31(4):e2190. PubMed ID: 33176028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "This is a Pakhtun disease": Pakhtun health journalists' perceptions of the barriers and facilitators to polio vaccine acceptance among the high-risk Pakhtun community in Pakistan.
    Shah SFA; Ginossar T; Weiss D
    Vaccine; 2019 Jun; 37(28):3694-3703. PubMed ID: 31155417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Needle-free injectors for mass administration of fractional dose inactivated poliovirus vaccine in Karachi, Pakistan: A survey of caregiver and vaccinator acceptability.
    Daly C; Molodecky NA; Sreevatsava M; Belayneh AD; Chandio SA; Partridge J; Shaikh A; Laghari M; Agbor J; Safdar RM; Bullo UF; Malik SM; Mahamud A
    Vaccine; 2020 Feb; 38(8):1893-1898. PubMed ID: 31983581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the last polio sanctuaries with Directly Observed Oral Polio Vaccination (DOPV) in northern Nigeria, (2014-2016).
    Korir C; Shuaib F; Adamu U; Bawa S; Musa A; Bashir A; Isiaka A; Ningi A; Warigon C; Richard B; Fiona B; Pascal M; Loveday N; Tegegne SG; Abdul-Aziz M; Suleiman A; Mohammed K; Corkum M; Onoka C; Nsubuga P; Yehualashet YG; Vaz RG; Alemu W
    BMC Public Health; 2018 Dec; 18(Suppl 4):1314. PubMed ID: 30541493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community engagement and integrated health and polio immunisation campaigns in conflict-affected areas of Pakistan: a cluster randomised controlled trial.
    Habib MA; Soofi S; Cousens S; Anwar S; Haque NU; Ahmed I; Ali N; Tahir R; Bhutta ZA
    Lancet Glob Health; 2017 Jun; 5(6):e593-e603. PubMed ID: 28495264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eradication and Current Status of Poliomyelitis in Pakistan: Ground Realities.
    Ghafoor S; Sheikh N
    J Immunol Res; 2016; 2016():6837824. PubMed ID: 27517055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the reasons for refusal of polio vaccine by families in Quetta Block, Pakistan.
    Zarak MS; Sana H; Arshad Z; Saleem A; Shah M; Tareen H; Ullah S; Baloch S; Kakar S; Kakar K
    East Mediterr Health J; 2022 Jul; 28(7):498-505. PubMed ID: 35959665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling the spread of polio in an IPV-vaccinated population: lessons learned from the 2013 silent outbreak in southern Israel.
    Yaari R; Kaliner E; Grotto I; Katriel G; Moran-Gilad J; Sofer D; Mendelson E; Miller E; Huppert A; ; Anis E; Kopel E; Manor Y; Mor O; Shulman L; Singer R; Weil M
    BMC Med; 2016 Jun; 14(1):95. PubMed ID: 27334457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Proactive and Reactive Strategies for Polio Eradication Activities in Pakistan and Afghanistan.
    Duintjer Tebbens RJ; Thompson KM
    Risk Anal; 2019 Feb; 39(2):389-401. PubMed ID: 30239026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deconstructing social resistance to pulse polio campaign in two North Indian districts.
    Chaturvedi S; Dasgupta R; Adhish V; Ganguly KK; Rai S; Sushant L; Srabasti S; Arora NK
    Indian Pediatr; 2009 Nov; 46(11):963-74. PubMed ID: 19736365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of Oral Polio Vaccine and Salk Inactive Polio Vaccine Against Xinjiang Imported Type 1 Wild Poliovirus.
    Yan D; Wang D; Zhu S; Zhang Y; Li X; Tang H; Guan J; Xu W
    Clin Infect Dis; 2020 Apr; 70(9):1980-1984. PubMed ID: 31240315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress Toward Poliomyelitis Eradication - Pakistan, January 2018-September 2019.
    Hsu CH; Kader M; Mahamud A; Bullard K; Jorba J; Agbor J; Safi MM; Jafari HS; Ehrhardt D
    MMWR Morb Mortal Wkly Rep; 2019 Nov; 68(45):1029-1033. PubMed ID: 31725710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study.
    Taniuchi M; Famulare M; Zaman K; Uddin MJ; Upfill-Brown AM; Ahmed T; Saha P; Haque R; Bandyopadhyay AS; Modlin JF; Platts-Mills JA; Houpt ER; Yunus M; Petri WA
    Lancet Infect Dis; 2017 Oct; 17(10):1069-1079. PubMed ID: 28693854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population Immunity against Serotype-2 Poliomyelitis Leading up to the Global Withdrawal of the Oral Poliovirus Vaccine: Spatio-temporal Modelling of Surveillance Data.
    Pons-Salort M; Molodecky NA; O'Reilly KM; Wadood MZ; Safdar RM; Etsano A; Vaz RG; Jafari H; Grassly NC; Blake IM
    PLoS Med; 2016 Oct; 13(10):e1002140. PubMed ID: 27701425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress toward poliomyelitis eradication--Nigeria, 2005-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(12):278-81. PubMed ID: 17392680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.